GARM: Multifocal Contact Lens Use in Previous Contact Lens Wearers With Near Vision Demands
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate the use of a multifocal contact lens in people who previously wore contact lenses but discontinued due to age-related, near vision demands.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Multifocal CL / Single vision CL + reading glasses Lotrafilcon B multifocal contact lenses (CL) worn first, with lotrafilcon B single vision contact lenses (CL) and over-reader spectacles worn second. Both contact lens products worn bilaterally on a daily wear basis; over-reader spectacles worn on an as-needed basis. |
Device: lotrafilcon B multifocal contact lens
Commercially marketed, silicone hydrogel, multifocal contact lens for daily wear use
Device: lotrafilcon B single vision contact lens
Commercially marketed, silicone hydrogel, single vision contact lens for daily wear use
Other: Over-reader spectacles
Reading glasses worn over single vision contact lenses for near vision work on an as-needed basis
|
Other: Single vision CL + reading glasses / Multifocal CL Lotrafilcon B single vision contact lenses (CL) and over-reader spectacles worn first, with lotrafilcon B multifocal contact lenses (CL) worn second. Both contact lens products worn bilaterally on a daily wear basis; over-reader spectacles worn on an as-needed basis. |
Device: lotrafilcon B multifocal contact lens
Commercially marketed, silicone hydrogel, multifocal contact lens for daily wear use
Device: lotrafilcon B single vision contact lens
Commercially marketed, silicone hydrogel, single vision contact lens for daily wear use
Other: Over-reader spectacles
Reading glasses worn over single vision contact lenses for near vision work on an as-needed basis
|
Outcome Measures
Primary Outcome Measures
- Overall Satisfaction With the Lenses [1 week of wear]
Overall satisfaction with the lenses was interpreted by and assessed by the subject as a single, retrospective measurement of one week's wear time. Overall satisfaction with the lenses was recorded on a questionnaire as a numerical rating on a scale of 1 to 100, with 1 being completely dissatisfied, and 100 being excellent, completely satisfied.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
has discontinued contact lens wear primarily due to age-related, near vision demands
-
requires a reading add of +0.50 to +1.75 D (inclusive) and is correctable to at least 6/9 monocular, distance and near with spectacle correction
-
has had an ocular examination in the last 2 years
-
Other protocol-defined inclusion/exclusion criteria may apply
Exclusion Criteria:
-
has any ocular disease
-
has more than a 2.00D prescription difference between eyes
-
cannot be fit successfully with the study contact lenses
-
has any systemic disease affecting ocular health
-
is using any systemic or topical medications that may affect ocular health
-
has undergone corneal refractive surgery
-
Other protocol-defined inclusion/exclusion criteria may apply
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Waterloo Centre for Contact Lens Research | Waterloo | Ontario | Canada | N2L 3G1 |
Sponsors and Collaborators
- CIBA VISION
- University of Waterloo
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- P-368-C-101
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Multifocal CL / Single Vision CL+ Reading Glasses | Single Vision CL + Reading Glasses / Multifocal CL |
---|---|---|
Arm/Group Description | Lotrafilcon B multifocal contact lenses (CL) worn first, with lotrafilcon B single vision contact lenses (CL) and over-reader spectacles worn second. Both contact lens products worn bilaterally on a daily wear basis; over-reader spectacles worn on an as-needed basis. | Lotrafilcon B single vision contact lenses (CL) and over-reader spectacles worn first, with lotrafilcon B multifocal contact lenses (CL) worn second. Both contact lens products worn bilaterally on a daily wear basis; over-reader spectacles worn on an as-needed basis. |
Period Title: Period 1, One Week of Wear | ||
STARTED | 8 | 8 |
COMPLETED | 8 | 8 |
NOT COMPLETED | 0 | 0 |
Period Title: Period 1, One Week of Wear | ||
STARTED | 8 | 8 |
COMPLETED | 8 | 8 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Overall Study |
---|---|
Arm/Group Description | This reporting group includes all enrolled and dispensed subjects. |
Overall Participants | 16 |
Age (years) [Mean (Standard Deviation) ] | |
Mean (Standard Deviation) [years] |
48.3
(4.5)
|
Sex: Female, Male (Count of Participants) | |
Female |
12
75%
|
Male |
4
25%
|
Outcome Measures
Title | Overall Satisfaction With the Lenses |
---|---|
Description | Overall satisfaction with the lenses was interpreted by and assessed by the subject as a single, retrospective measurement of one week's wear time. Overall satisfaction with the lenses was recorded on a questionnaire as a numerical rating on a scale of 1 to 100, with 1 being completely dissatisfied, and 100 being excellent, completely satisfied. |
Time Frame | 1 week of wear |
Outcome Measure Data
Analysis Population Description |
---|
Analysis conducted per protocol |
Arm/Group Title | Lotrafilcon B Multifocal Contact Lens | Lotrafilcon B Single Vision Contact Lens + Reading Glasses |
---|---|---|
Arm/Group Description | Commercially marketed, lotrafilcon B, silicone hydrogel, multifocal contact lens for daily wear use | Commercially marketed, lotrafilcon B, silicone hydrogel, single vision contact lenses for daily wear use, with over-reader spectacles worn as needed |
Measure Participants | 16 | 16 |
Mean (Standard Deviation) [Units on a Scale] |
82.5
(14.5)
|
64.4
(22.9)
|
Adverse Events
Time Frame | Adverse event data were collected for the duration of the trial. Individual subject exposure = 1 week per product, total 2 weeks. | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Multifocal Contact Lens | Single Vision Contact Lens | ||
Arm/Group Description | Commercially marketed lotrafilcon B multifocal contact lenses | Commercially marketed lotrafilcon B single vision contact lenses | ||
All Cause Mortality |
||||
Multifocal Contact Lens | Single Vision Contact Lens | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
Multifocal Contact Lens | Single Vision Contact Lens | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/16 (0%) | 0/16 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Multifocal Contact Lens | Single Vision Contact Lens | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/16 (0%) | 0/16 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
No distribution of trial-specific information without express written permission of director.
Results Point of Contact
Name/Title | Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs |
---|---|
Organization | CIBA VISION |
Phone | 1-800-241-7629 |
priya.janakiraman@cibavision.com |
- P-368-C-101